Document Type
Journal Article
Publication Title
Asia Pacific Journal of Public Health
Publisher
SAGE
School
Centre for Research in Aged Care / Graduate Research School
RAS ID
64553
Abstract
Betel Quid (BQ) is commonly used in the Asia-Pacific region. Disulfiram is prescribed for people with alcohol use disorders (PwAUDs) after the completion of detoxification as an alternative to rehabilitation. This prospective observational study reports the aversive reactions and common symptoms of Disulfiram and BQ in PwAUDs. Participants included PwAUDs admitted to the psychiatric ward at the Jigme Dorji Wangchuck National Referral Hospital for detoxification, who were on Disulfiram and using BQ at the same time. Aversive reactions between Disulfiram and BQ were observed for 100 patients over a year. Twenty participants showed aversive reactions between BQ and Disulfiram. Common symptoms included sweating, diarrhea, dizziness, tremors, palpitations, shortness of breath, nausea and vomiting, and headache. Since PwAUDs in Bhutan are inducted on Disulfiram after detoxification, and most use BQ simultaneously, this study will help inform health care providers to educate people about the aversive reactions of Disulfiram and BQ.
DOI
10.1177/10105395231204801
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Comments
Dem, U., Letho, Z., Dorji, C., Nirola, D. K., Choki, S., Dorji, T., & Chejor, P. (2023). Aversive reaction between disulfiram and betel quid among inpatients with alcohol use disorder in Bhutan: A preliminary study. Asia Pacific Journal of Public Health, 35(8), 532-534. https://doi.org/10.1177/10105395231204801